News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
766,859 Results
Type
Article (52222)
Company Profile (460)
Press Release (714162)
Multimedia
Podcasts (168)
Webinars (23)
Section
Business (211425)
Career Advice (2102)
Deals (36509)
Drug Delivery (152)
Drug Development (85840)
Employer Resources (175)
FDA (17101)
Job Trends (15354)
News (358849)
Policy (33798)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (3)
2027 Genetown Standard (4)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (2839)
Academic (1)
Accelerated approval (58)
ADA (49)
Adcomms (36)
Allergies (199)
Alliances (51843)
ALS (238)
Alzheimer's disease (1919)
Antibody-drug conjugate (ADC) (566)
Approvals (17531)
Artificial intelligence (777)
ASCO (343)
Autoimmune disease (366)
Automation (66)
Bankruptcy (380)
Best Places to Work (11919)
BIO (72)
BIOSECURE Act (21)
Biosimilars (241)
Biotechnology (321)
Bladder cancer (210)
Brain cancer (81)
Breast cancer (837)
Cancer (6617)
Cardiovascular disease (529)
Career advice (1790)
Career pathing (46)
CAR-T (388)
CDC (63)
Celiac Disease (3)
Cell therapy (1076)
Cervical cancer (57)
Clinical research (74537)
Collaboration (2352)
Commercialization (1)
Company closure (5)
Compensation (1523)
Complete response letters (100)
COVID-19 (2897)
CRISPR (127)
C-suite (1297)
Cystic fibrosis (165)
Data (8838)
Decentralized trials (3)
Denatured (51)
Depression (188)
Dermatology (100)
Diabetes (677)
Diagnostics (7196)
Digital health (64)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (394)
Drug pricing (218)
Drug shortages (33)
Duchenne muscular dystrophy (325)
Earnings (93953)
Editorial (72)
Employer branding (21)
Employer resources (155)
Events (125871)
Executive appointments (1170)
FDA (21198)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (36)
Funding (1945)
Gene editing (272)
Generative AI (66)
Gene therapy (842)
GLP-1 (1158)
Government (4933)
Grass and pollen (6)
Guidances (420)
Healthcare (19703)
Hematology (198)
HIV (95)
Huntington's disease (67)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (115)
Immunology and inflammation (345)
Immuno-oncology (119)
Indications (223)
Infectious disease (3275)
Inflammatory bowel disease (238)
Inflation Reduction Act (17)
Influenza (147)
Intellectual property (325)
Interviews (334)
IPO (17066)
IRA (53)
Job creations (3756)
Job search strategy (1475)
JPM (69)
Kidney cancer (22)
Labor market (112)
Layoffs (630)
Leadership (45)
Legal (8128)
Liver cancer (108)
Longevity (37)
Lung cancer (883)
Lymphoma (488)
Machine learning (67)
Management (60)
Manufacturing (1207)
Marketing (4)
MASH (219)
Medical affairs (1)
Medical device (14239)
Medtech (14413)
Mergers & acquisitions (20755)
Metabolic disorders (1732)
mRNA (263)
Multiple sclerosis (208)
NASH (20)
Neurodegenerative disease (500)
Neuropsychiatric disorders (120)
Neuroscience (3656)
Neurotech (1)
NextGen: Class of 2026 (6861)
Non-profit (4683)
Now hiring (82)
Obesity (813)
Opinion (326)
Ovarian cancer (247)
Pain (273)
Pancreatic cancer (367)
Parkinson's disease (419)
Partnered (38)
Patents (654)
Patient recruitment (795)
Peanut (69)
People (61888)
Pharmaceutical (75)
Pharmacy benefit managers (34)
Phase 1 (23462)
Phase 2 (32856)
Phase 3 (24289)
Pipeline (10028)
Policy (356)
Postmarket research (2668)
Preclinical (10281)
Press Release (70)
Prostate cancer (346)
Psychedelics (68)
Radiopharmaceuticals (369)
Rare diseases (1272)
Real estate (6180)
Recruiting (72)
Regulatory (26779)
Reports (57)
Research institute (2621)
Resumes & cover letters (365)
Rett syndrome (46)
RNA editing (31)
RSV (92)
Schizophrenia (190)
Series A (336)
Series B (248)
Service/supplier (11)
Sickle cell disease (130)
Special edition (32)
Spinal muscular atrophy (178)
Sponsored (50)
Startups (3873)
State (2)
Stomach cancer (21)
Supply chain (141)
Tariffs (90)
The Weekly (114)
Vaccines (1210)
Venture capital (132)
Weight loss (527)
Women's health (143)
Worklife (22)
Date
Today (127)
Last 7 days (517)
Last 30 days (2585)
Last 365 days (31533)
2026 (16764)
2025 (31394)
2024 (36617)
2023 (41364)
2022 (52662)
2021 (57158)
2020 (55392)
2019 (47949)
2018 (36136)
2017 (33590)
2016 (33045)
2015 (39130)
2014 (32927)
2013 (28280)
2012 (30297)
2011 (30732)
2010 (28849)
Location
Africa (787)
Alabama (99)
Alaska (7)
Arizona (378)
Arkansas (16)
Asia (42700)
Australia (7294)
California (14308)
Canada (4006)
China (1574)
Colorado (617)
Connecticut (633)
Delaware (438)
Europe (95103)
Florida (2134)
Georgia (454)
Hawaii (3)
Idaho (64)
Illinois (1186)
India (99)
Indiana (639)
Iowa (27)
Japan (611)
Kansas (139)
Kentucky (55)
Louisiana (60)
Maine (89)
Maryland (1694)
Massachusetts (10450)
Michigan (380)
Minnesota (775)
Mississippi (6)
Missouri (151)
Montana (35)
Nebraska (31)
Nevada (149)
New Hampshire (89)
New Jersey (3758)
New Mexico (34)
New York (3750)
North Carolina (1866)
North Dakota (11)
Northern California (7204)
Ohio (426)
Oklahoma (24)
Oregon (44)
Pennsylvania (2822)
Puerto Rico (32)
Rhode Island (53)
South America (1177)
South Carolina (87)
South Dakota (2)
Southern California (5641)
Tennessee (232)
Texas (2297)
United States (50738)
Utah (421)
Vermont (2)
Virginia (356)
Washington D.C. (82)
Washington State (1167)
West Virginia (4)
Wisconsin (142)
Wyoming (2)
766,859 Results for "cell therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Telos Biotech Announces Strategic Evaluation Collaboration with Made Scientific to Assess TELOVANCE™ Across Multiple Cell Therapy Manufacturing Platforms
Collaboration will evaluate TELOVANCE™ in CAR T-cell, NK-cell, and hematopoietic stem/progenitor cell workflows to generate feasibility data across therapeutically relevant cell types
June 19, 2026
·
1 min read
M&A
Merck KGaA inks $11B Bio-Techne buyout to expand into cell therapy production
The company is “especially excited” about an immune cell therapy manufacturing technology included in the deal, a Merck KGaA executive said.
June 26, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
Deck Bio to Present Multi-pMHC T Cell Engager Platform at the 8th T-Cell Engager Therapeutics Summit and BIO 2026
June 19, 2026
·
2 min read
Press Releases
Takara Bio USA, Inc. to Showcase Instrument-Free Approach to Spatial Biology at Human Cell Atlas 2026 Meeting
June 16, 2026
·
4 min read
Editorial
BIO 2026: Cell and gene therapy sector must break the mold to thrive
If cell and gene therapy makers are going to achieve their mission to improve patients’ lives, the industry must come together to share information across stakeholders, from regulators to manufacturers to payers.
June 22, 2026
·
4 min read
·
Jef Akst
Press Releases
Voro Therapeutics and Alloy Therapeutics Enter Strategic Research Collaboration to Advance Next-Generation Masked T-Cell Engager Therapeutics
June 19, 2026
·
4 min read
Press Releases
TScan Therapeutics to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
June 24, 2026
·
1 min read
Venture capital
Lilly-Backed China Startup Debuts With $68.7M Seed to Advance Next-Gen T Cell Engagers
Excalipoint Therapeutics will use its seed money to advance a pipeline of cancer therapies, including a tri-specific antibody for small cell lung cancer and neuroendocrine tumors.
March 18, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Medexus Announces License and Supply Deal for UM171 Cell Therapy in Canada
UM171 Cell Therapy is conditionally approved in Europe as Zemcelpro® (dorocubicel) Securing Canadian rights to a proprietary advanced clinical-stage product candidate developed in Canada adds to Medexus’s medium-term product pipeline and helps build a North American allo-HSCT franchise
June 10, 2026
·
16 min read
Press Releases
Calidi Biotherapeutics Presents New Data on CLD-501, Its In Situ T-Cell Engager Candidate Targeting TROP-2 at the T-Cell Engager Therapeutic Summit
June 24, 2026
·
5 min read
1 of 76,686
Next
